RUNX1 and breast cancer: It is intriguing that even though RUNX1 was expressed in most breast cancer cell lines (Figure 1) and the majority of patients (Table S1) regardless of hormonal status, it was only in the hormone-negative patients that RUNX1 expression correlated with patient outcome.